Biotrin Launches MDx Project for DNA, RNA Detection | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Irish diagnostics firm Biotrin announced today a new R&D project to develop automated molecular diagnostics platform technology and assay reagents to detect target DNA and RNA in infectious diseases.

The technology will be based on loop-mediated isothermal amplification, which uses a single temperature incubation.

The project is expected to create 40 new jobs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.